Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eleven brokerages that are presently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $301.73.
Several equities analysts have commented on AXON shares. TheStreet downgraded shares of Axon Enterprise from a “b” rating to a “c+” rating in a report on Tuesday, February 27th. JPMorgan Chase & Co. upped their price objective on shares of Axon Enterprise from $285.00 to $330.00 and gave the company an “overweight” rating in a report on Wednesday, February 28th. Argus assumed coverage on shares of Axon Enterprise in a report on Wednesday, March 13th. They issued a “buy” rating and a $380.00 price objective on the stock. Needham & Company LLC upped their price target on shares of Axon Enterprise from $240.00 to $315.00 and gave the company a “buy” rating in a research note on Wednesday, February 28th. Finally, StockNews.com downgraded shares of Axon Enterprise from a “buy” rating to a “hold” rating in a research note on Thursday, March 14th.
View Our Latest Analysis on Axon Enterprise
Axon Enterprise Stock Performance
NASDAQ AXON opened at $312.88 on Friday. The company has a current ratio of 3.00, a quick ratio of 2.66 and a debt-to-equity ratio of 0.42. The firm’s fifty day moving average price is $285.73 and its two-hundred day moving average price is $247.10. Axon Enterprise has a 1 year low of $175.37 and a 1 year high of $325.63. The firm has a market capitalization of $23.61 billion, a P/E ratio of 136.03 and a beta of 0.93.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its quarterly earnings results on Tuesday, February 27th. The biotechnology company reported $0.77 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.48 by $0.29. Axon Enterprise had a net margin of 11.14% and a return on equity of 14.11%. The firm had revenue of $432.14 million for the quarter, compared to analyst estimates of $418.97 million. As a group, research analysts anticipate that Axon Enterprise will post 2.43 EPS for the current year.
Insiders Place Their Bets
In other news, President Joshua Isner sold 35,400 shares of the stock in a transaction dated Tuesday, January 2nd. The shares were sold at an average price of $251.68, for a total value of $8,909,472.00. Following the completion of the transaction, the president now owns 309,564 shares of the company’s stock, valued at $77,911,067.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 6.10% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently made changes to their positions in the stock. ICA Group Wealth Management LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth about $25,000. Hollencrest Capital Management bought a new position in Axon Enterprise in the 1st quarter valued at approximately $29,000. BKM Wealth Management LLC bought a new position in Axon Enterprise in the 4th quarter valued at approximately $32,000. First Capital Advisors Group LLC. bought a new position in Axon Enterprise in the 2nd quarter valued at approximately $33,000. Finally, Tyler Stone Wealth Management bought a new position in Axon Enterprise in the 2nd quarter valued at approximately $35,000. Institutional investors own 79.08% of the company’s stock.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
Receive News & Ratings for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.
